Table 3.
Disease Spectrum of Fatty Acid Oxidation Defects
| FAOD | n | Of all cases of FAOD (%) | Of all confirmed cases (%) | Of all tested cases (‰) |
|---|---|---|---|---|
| MADD | 79 | 53.7 | 7.0 | 4.3 |
| CTD | 28 | 19.0 | 2.5 | 1.5 |
| VLCAD | 18 | 12.2 | 1.6 | 1.0 |
| SCAD | 13 | 8.8 | 1.1 | 0.7 |
| MCAD | 3 | 2.0 | 0.3 | 0.2 |
| CPT‐I | 3 | 2.0 | 0.3 | 0.2 |
| CPT‐II | 3 | 2.0 | 0.3 | 0.2 |
| Total | 147 | 100.0 | 13.0 | 8.0 |
FAOD, fatty acid oxidation defect; MADD, multiple acyl‐coenzyme A dehydrogenase deficiency; CTD, carnitine transport defect; VLCAD, very long chain acyl‐coenzyme A dehydrogenase deficiency; SCAD, short‐chain acyl‐coenzyme A dehydrogenase deficiency; MCAD, medium‐chain acyl‐coenzyme A dehydrogenase deficiency; CPT‐I, carnitine palmitoyl transferase I deficiency; CPT‐II, carnitine palmitoyl transferase II deficiency.